FDA Law Blog: International Pharmaceutical and Medical Device Supply Chains Imperiled Like Never Before - A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC

FDA Law Blog: International Pharmaceutical and Medical Device Supply Chains Imperiled Like Never Before - A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC

International Pharmaceutical and Medical Device Supply Chains Imperiled Like Never Before - A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC Posted: 16 Aug 2016 03:43 PM PDT   In recent years, the level of scrutiny on foreign pharmaceutical manufacturing facilities in countries like China and India has skyrocketed—along with the demand and dependence of western countries on the supply of goods coming from those facilities. Furthermore, increased enforcement aimed at the medical device industry and the safety and effectiveness of medical device production have become a key focus of global regulators. With the latest updates to the global standard for medical device quality management systems and the proposed new EU Medical Device Regulations, device manufacturers, service providers, and supply chain partners will need to closely assess their product lifecycle risk management systems to ensure they are complying with requirements. This webinar will discuss these recent pharmaceutical and medical device supply chain developments and what steps companies need to take to prevent and remediate compliance issues in the context of: The uptick in investigations in China and India. Speed vs. Safety: the approval process differences between the EU and U.S. Increased scrutiny of non-EU-based manufactures and requirements for importers and distributors. The potential impact of adverse regulatory actions against nonconforming facilities. Threats posed by bribery and corruption. Anti-corruption compliance issues from U.S. and Asian perspectives. “War stories” from recent investigations. When Wednesday, September 14, 2016 1:30 p.m. - 2:30 p.m. BST Where This presentation will be simulcast via Webex as a webinar.  Please click here to register. Speakers Douglas B. Farquhar Director Hyman, Phelps & McNamara PC Washington, D.C. Mark I. Schwartz Of Counsel Hyman, Phelps & McNamara PC Washington, D.C. Jeremy B. Zucker  Partner Dechert LLP Washington, D.C. Lewis Ho Partner Dechert LLP Hong Kong Kareena Teh Partner Dechert LLP Hong Kong Application for accreditation of this program for Continuing Professional Development (CPD) in the United Kingdom is currently pending. For questions, please contact Reiko Tate (reiko.tate@dechert.com).